Urinary excretion of type I collagen cross-linked N-telopeptides, bone mass and related lifestyle in middle-aged women

Acta Medica Okayama

Volumn 53, Issue 3, 1999, Pages 133-140

  Masatomi, Chie ^a   Imai, Kaori ^a   Wang, Da Hong ^a   Ikeda, Satoru ^a   Taketa, Kazuhisa ^b   Takata, Shinji ^c   Kira, Shohei ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Ibara City Hospital   (Japan)

^c OKAYAMA SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

Bone turnover; Lifestyle; Menopause; N telopeptides; Osteoporosis

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ADULT; ARTICLE; BONE; BONE DENSITY; CALCIUM INTAKE; COMPARATIVE STUDY; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HUMAN; JAPAN; LIFESTYLE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; PREDICTION AND FORECASTING; PREMENOPAUSE; REGRESSION ANALYSIS; URINE;

ADULT; BONE AND BONES; BONE DENSITY; CALCIUM, DIETARY; COLLAGEN; COLLAGEN TYPE I; DIET; EXERCISE; FEMALE; HEALTH BEHAVIOR; HUMANS; JAPAN; LIFE STYLE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; REGRESSION ANALYSIS;

EID: 0033145690     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sinaki M: Exercise and osteoporosis. Arch Phys Med Rehabil (1989) 70, 220-229.
2. WHO: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series-843, Geneva, Switzerland, 1994.
3. Lindsay R: Estrogen, bone mass, and osteoporotic fracture. Am J Med (1991) 91, 10S-13S.
4. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ and Delmas PD: Markers of bone resorption predict hip fracture in elderly woman: The EPIDOS Prospective Study. J Bone Miner Res (1996) 11, 1531-1538.
5. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD and Greenspan SL: Specificity of urinary excretion of cross-linked N-telepeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int (1994) 54, 26-29.
6. Inoue T, Kushida K, Kumazawa Y, Harada S, Hayashi Y, Nakajima I, Akamatsu N, Tanizawa T, Takahashi H, Aoyama K, Matsubayashi T, Takahashi M, Sano M, Ishikawa M, Sumi Y, Watanabe K, Sudo A, Uchida A, Ueyoshi A, Tamaki T, Doita M, Mizuno K, Yoh K, Maruo S, Hagino H, Yamamoto K, Morimoto K, Imai H, Watanabe R, Mori S and Norimatsu H: Clinical usefulness of urinary type I collagen N-telopeptide crosslinks (NTx) in monitoring of effects while on therapy in osteoporosis. Geriat Med (1997) 35, 1441-1447 (in Japanese).
7. Takami H, Mimura T, Ohara T, Nakazawa H, Kobayashi S, Funabashi H and Tominaga Y: Clinical application of the assay of type I collagen cross-linked N-telopeptides in patients with primary hyperparathyroidism. The second report.: A marker of assessment of efficacy for parathyroidectomy. Clin Endoclinol (1996) 44, 321-326 (in Japanese).
8. Melton LJ 3rd, Khosla S, Atokinson EJ, O'Fallon WM and Riggs BL: Relationship of bone turnover to bone density and fractures. J Bone Miner Res (1997) 12, 1083-1091.
9. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR and Eyre DR: A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res (1992) 7, 1251-1258.
10. Gertz BJ, Shao P, Hanson DA, Quan H, Harris ST, Genant HK, Chesnut CH III and Eyre DR: Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res (1994) 9, 135-142.
11. de la Piedra C, Trada ML, Dominguez Cabrera C and Sosa Henriquez M: New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. Clin Chim Acta (1997) 265, 225-234.
12. Sone T, Miyake M, Takeda N and Fukunaga M: Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: Age- and sex-related changes and reference limits. Bone (1995) 17, 335-339.
13. Krall EA, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS and Dalsky G: Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women. J Gerontol A Biol Sci Med Sd (1997) 52, M61-M67.
14. Gorai I, Taguchi Y, Chaki O, Nakayama M and Minaguchi H: Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: Correlation with other markers of bone turnover. Calcif Tissue Int (1997) 60, 317-322.
15. Kawana K, Kushida K, Takahashi M, Ohishi T, Denda M, Yamazaki K and Inoue T: The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Calcif Tissue Int (1994) 55, 420-425.
16. Garnero P, Arden NK, Griffiths G, Delmas PD and Spector TD: Genetic influence on bone turnover in postmenopausal twins. J Clin Endocrinol Metab (1996) 81, 140-146.
17. American College of Sports Medicine: Guidelines for Exercise Testing and Prescription. 4th Ed, Lea and Febiger, Philadelphia (1991) pp102 -105
18. Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, Niimi H, Shiraki M, Ohara T, Shishiba Y, Tsuchiya Y, Takahashi H, Takatsuki K, Seino Y, Morii H, Fujita T, Okamoto S and Ogata E: Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies. Clin Endoclinol (1990) 38, 1291-1296 (in Japanese).
19. Miki T, Nakatsuka K, Ezawa I and Satoh K: Measurement of serum Bone-ALP concentration with enzyme-immunoassay. Clin Endoclinol (1997) 45, 999-1004 (in Japanese).
20. Poilles JM, Tremollieres F and Ribot C: The effect of menopause on longitudinal bone loss from the spine. Calcif Tissue Int (1993) 52, 340-343.
21. Nilas L and Christiansen C: The pathophysiology of peri- and postmenopausal bone loss. Br J Obster Gynaecol (1989) 96, 580-587.
22. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW and Haussier MR: Estrogen binding, receptor mRNA, and biologic response in osteoblast- like osteosarcoma cells. Science (1988) 241, 81-84.
23. Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH: Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab (1990) 70, 7180-723.
24. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H and Manolagas SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science (1992) 257, 88-91.
25. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crotts L, Nguyen TV, Sambrook PN and Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature (1994) 367, 284-287.
26. Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN and Eisman JA: Genetic factors in bone turnover. J Clin Endocrinol Metab (1991) 72, 808-813.
27. Metz JA, Anderson JJ and Gallangher PN Jr: Intakes of calcium, phosphorus, and protein, and physical-activity level are related to radial bone mass in young adult women. Am J Clin Nutr (1993) 58, 537-542.
28. Valimaki MJ, Karkkainen M, Lamberg-Allardt C, Laitinen K, Alhava E, Heikkinen J, Impivaara O, Makela P, Palmgren J, Seppanen R and Vuori I: Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Finns Study Group. BMJ (1994) 309, 230-235.
29. Ulrich CM, Georgiou CC, Snow-Harter CM and Gillis DE: Bone mineral density in mother-daughter pairs: Relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr (1996) 63, 72-79.
30. Jurkowski JE, Jones NL, Walker C, Younglai EV and Sutton JR: Ovarian hormonal responses to exercise. J Appl Physiol (1978) 44, 109-114.